Cita APA

Araki, E., Onishi, Y., Asano, M., Kim, H., Ekholm, E., Johnsson, E., & Yajima, T. (2016). Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16‐week double‐blind treatment period. J Diabetes Investig.

Chicago Style Citation

Araki, Eiichi, Yukiko Onishi, Michiko Asano, Hyosung Kim, Ella Ekholm, Eva Johnsson, i Toshitaka Yajima. "Efficacy and Safety of Dapagliflozin in Addition to Insulin Therapy in Japanese Patients With Type 2 Diabetes: Results of the Interim Analysis of 16‐week Double‐blind Treatment Period." J Diabetes Investig 2016.

Cita MLA

Araki, Eiichi, et al. "Efficacy and Safety of Dapagliflozin in Addition to Insulin Therapy in Japanese Patients With Type 2 Diabetes: Results of the Interim Analysis of 16‐week Double‐blind Treatment Period." J Diabetes Investig 2016.